Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Patrick's Penny Players' Paradise -- Ignore unavailable to you. Want to Upgrade?

To: PitBull who wrote (49)	7/15/1998 12:51:00 PM
From: Warlock	Read Replies (1) \| Respond to of 275

PWLS: formerly Pratt Wylce and Lords, now Bionet Technologies. Following as of July, 1998: Shares outstanding: 5,237,270 Float: 1,080,997 Independent Auditors: Schifley & Associates Transfer Agent: Florida Atlantic Trust and Transfer President: L. Alan Schafler Subsidieries: Immune Technologies: (develops immunology products) President: Larry Zoner Revenue Projections: 1999-$1,500,000 2000-$17,000,000 2001-$34,000,000 2002-$54,000,000 Greengold: (aquaculture crop production using wastewater as fertilizer. Will initially be used in the North Carolina hog market). COO: Paul Skillicorn Revenue Projections: 1999-$850,000 2000-$11,000,000 2001-$34,000,000 2002-$84,000,000 I'd advise that you review the most recent company press releases. For further questions, I may know more details. Also, can contact Timothy Miles at 843/686-5590. Here is a copy of the SI thread which has a bit more info. Let me know if you have any questions. Patrick. Notice should be taken of BioNet Technologies. They have just announced their second acquisition and seem poised to take off. After a year and a half spent on reorgainzing the company with trading in the $.20 to $.50 range they are back on track as a multidivisional biotech company with a focus on consolidation. BioNet itself is run by a seasoned veteran with NYSE CEO experience and both acquisitions are loaded with credible individuals. I suggest you take the time to check this one out. Their first acquisition, Immune Technologies has proprietary products resulting from "immune modulation technology" with a focus on the veterinary side of the business. The veterinary focus is to achieve early cash flow. I applaud this move. The newest candidate "The Greengold Corporation" is headed up by "the worlds formost authority on duckweed production" and has patented technology which will, according to the company, have a huge impact on the animal waste problem globally as well as producing healthy cashflow in the process. I made a few calls and this one seems loaded with potential. I understand BioNet is working on implementing a financial PR program for the first time in its history as well. Sounds like the perfect opportunity to me. With just over 5 Million outstanding and 1 million in the float, we should see some significant short term gains as the investing public discovers this baby conglomerate with good long term prospects as well as the company continues to build its stable of acquisitions. I see this as a steal under $1 and a value to $2 once the second acquisition closes. I have started this thread under "PWLS - BioNet Technologies" as well. We will see which one takes off. Take your pick.